HRT Financial’s Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share SGHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-47,698
Closed -$29K 3793
2022
Q2
$29K Sell
47,698
-14,357
-23% -$24.5K ﹤0.01% 2569
2022
Q1
$178K Buy
+62,055
New +$109K ﹤0.01% 2524

Other funds holding SGHC.WS

HRT Financial's SGHC.WS Position: Q3 2022 in Review

HRT Financial sold out of Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share (SGHC.WS) in Q3 2022, closing a stake of 47,698 shares — an estimated $29K sold.

HRT Financial first reported a position in SGHC.WS in Q1 2022 and held it in 2 quarters. The position peaked at $178K in Q1 2022. 17 funds tracked by Wall St. Rank hold SGHC.WS as of Q3 2022.

  • HRT Financial reported no remaining Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 47,698 Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share shares in Q3 2022, an estimated $29K.
  • HRT Financial first reported a position in Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share in Q1 2022 and held it in 2 quarters.
  • HRT Financial's Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position peaked at $178K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.